Maxigen Biotech Inc. (TPE:1783)

Taiwan · Delayed Price · Currency is TWD

46.75

-0.05 (-0.11%)

Jan 22, 2026, 1:35 PM CST

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biomedical	698.34M	Log In	Log In
Biomedical Growth	8.34%	Log In	Log In
Adjustments and Reversals	-17.69M	Log In	Log In
Adjustments and Reversals Growth	-58.73%	Log In	Log In
Consumer	-	Log In	Log In
Consumer Growth	-	Log In	Log In

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Taiwan	298.86M	Log In	Log In
Taiwan Growth	8.43%	Log In	Log In
United States	196.57M	Log In	Log In
United States Growth	-1.13%	Log In	Log In
Asia	75.12M	Log In	Log In
Asia Growth	-21.60%	Log In	Log In
Europe	58.98M	Log In	Log In
Europe Growth	111.19%	Log In	Log In
Other	51.13M	Log In	Log In
Other Growth	113.59%	Log In	Log In